Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/14/2002 | CA2446528A1 Disinfecting and solubilizing steroid compositions |
11/14/2002 | CA2446204A1 Anti-virus agent |
11/14/2002 | CA2446060A1 Compositions and delivery systems for administration of a local anesthetic agent |
11/14/2002 | CA2445985A1 Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells |
11/14/2002 | CA2445933A1 Gelatin substitute |
11/14/2002 | CA2445065A1 Trimethyl lock based tetrapartate prodrugs |
11/14/2002 | CA2444718A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
11/13/2002 | EP1256354A1 Methods for treating cancer |
11/13/2002 | EP1256346A1 Remedies for external use for allergic skin diseases |
11/13/2002 | EP1256340A1 Improved transdermal therapeutic system for the treatment of Parkinson's disease |
11/13/2002 | EP1256339A1 Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine |
11/13/2002 | EP1256336A2 Two-phase gel composition |
11/13/2002 | EP1255845A2 Modified cytokines for use in cancer therapy |
11/13/2002 | EP1255823A1 Slow release protein polymers |
11/13/2002 | EP1255793A1 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
11/13/2002 | EP1255780A1 Methods and compositions for generating human monoclonal antibodies |
11/13/2002 | EP1255725A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
11/13/2002 | EP1255576A1 Mineral-polymer hybrid composition |
11/13/2002 | EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
11/13/2002 | EP1255568A2 Conjugates targeted to target receptors |
11/13/2002 | EP1255567A1 Selective cellular targeting: multifunctional delivery vehicles |
11/13/2002 | EP1255566A2 Preparation of aqueous clear solution dosage forms with bile acids |
11/13/2002 | EP1255565A1 Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
11/13/2002 | EP1255563A1 Composition of antigen and glycolipid adjuvant sublingual administration |
11/13/2002 | EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
11/13/2002 | EP1255557A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
11/13/2002 | EP1255552A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
11/13/2002 | EP1255545A2 L-arginine in combination with other compounds for treating cardiovascular diseases |
11/13/2002 | EP1255544A1 Mucin synthesis inhibitors |
11/13/2002 | EP1255535A2 Controlled release pharmaceutical composition containing tramadol hydrochloride |
11/13/2002 | EP1255534A2 Method for the preparation of microspheres which contain colloidal systems |
11/13/2002 | EP1255532A1 Osmotically-driven fluid dispenser and coating composition |
11/13/2002 | EP1255445A1 Method of filtration of a dairy stream |
11/13/2002 | EP1255439A1 Therapeutic platelets and methods |
11/13/2002 | EP1140200B1 Anthraquinone anticancer drugs |
11/13/2002 | EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
11/13/2002 | EP0991407B9 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations |
11/13/2002 | EP0777477B1 Improved pharmaceutical formulations containing ibuprofen and codeine |
11/13/2002 | EP0756496B1 Dendrimeric compounds |
11/13/2002 | EP0735863B1 Accelerated release composition containing bromocriptine |
11/13/2002 | EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
11/13/2002 | EP0693935B1 Method and compositions for digesting tissue |
11/13/2002 | EP0618807B1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
11/13/2002 | CN1379821A Nucleic acid transporter containing polypeptide and recombinant virus vector |
11/13/2002 | CN1379769A Novel composition and method or stabilizing same |
11/13/2002 | CN1379768A Improved aqueous solubility pharmaceutical formulations |
11/13/2002 | CN1379687A Magnetic nanoparticles having biochemial activity, method for production thereof and their use |
11/13/2002 | CN1379684A Treating prostate cancer with anti-ErbB2 antibodies |
11/13/2002 | CN1379683A 疫苗 Vaccine |
11/13/2002 | CN1379678A Method for calming human beings using personal care compositions |
11/13/2002 | CN1379674A Ciclesonide contained pharmaceutical composition for application to mucosa |
11/13/2002 | CN1379673A Ciclesonide-containing aqueous pharmaceutical composition |
11/13/2002 | CN1379669A Valdecoxib compositions |
11/13/2002 | CN1379667A Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
11/13/2002 | CN1379663A Vaccine composition and method of using same |
11/13/2002 | CN1379623A Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
11/13/2002 | CN1379068A Low foaming N-alkyl-tartraimine and N-alkyl melicimine wetting agent |
11/13/2002 | CN1379052A Polyasparamide derivative and process for preparing its nano capsules |
11/13/2002 | CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process |
11/13/2002 | CN1094063C Methods for preparing monomeric calicheamicin derivative/carrier conjugates |
11/12/2002 | US6479637 Hemoglobin-haptoglobin complexes |
11/12/2002 | US6479627 Aqueous preparation of lactoferrin having improved stability |
11/12/2002 | US6479551 Treatment of migraine headache |
11/12/2002 | US6479541 Amiodarone-containing parenteral administration |
11/12/2002 | US6479540 Compositions of tocol-soluble therapeutics |
11/12/2002 | US6479529 Antioxidant stabilizer system for pharmaceutical formulations |
11/12/2002 | US6479496 Treating a human patient suffering from variant and exercise-induced angina by administering a sustained release pharmaceutical dosage form including at least 50% by weight ranolazine in no more than two tablets per dose |
11/12/2002 | US6479468 Oxidized and reduced polysaccharide exhibits a longer vascular half-life than unmodified starch, slower degradation by amylase than unmodified starch, and/or slower the smaller the allergenicity |
11/12/2002 | US6479461 Use of alkylmonoglucosides as molecular vectors |
11/12/2002 | US6479457 Polypeptide comprising at least one effective ionogenic amine ionically bound to polymer; drug delivery systems for the controlled release of pharmaceutical polypeptides |
11/12/2002 | US6479076 Nicotine delivery compositions |
11/12/2002 | US6479074 Methods and transdermal compositions for pain relief |
11/12/2002 | US6479067 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
11/12/2002 | US6479060 Elegant hydrogenated castor oil ointments |
11/12/2002 | US6479058 Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
11/12/2002 | US6479049 Methods and compositions for the dry powder formulation of interferons |
11/12/2002 | US6479048 Foam inhibitor comprising hydrophobic amino acid which is suitable for inhibiting foaming induced when dissolving a dry composition containing saccharide; preferably has a hydropathy index of not less than 2. |
11/12/2002 | US6479045 Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis |
11/12/2002 | US6479039 Antimicrobial artificial nail composition and methods for preparing and using same |
11/12/2002 | US6479035 Pharmaceutical formulation of fluticasone propionate |
11/12/2002 | US6479034 Method of preparing gas and gaseous precursor-filled microspheres |
11/12/2002 | US6479033 Antitumor cystostatic and contrast agent |
11/12/2002 | CA2266478C Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
11/12/2002 | CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
11/12/2002 | CA2195318C Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
11/12/2002 | CA2119109C Bioadhesive ophthalmic insert |
11/12/2002 | CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them |
11/12/2002 | CA2090920C Opacifier for water-based compositions |
11/12/2002 | CA2088917C Therapeutic ribozyme compositions |
11/12/2002 | CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same |
11/12/2002 | CA2071518C Oral composition for the treatment of inflammatory bowel diseases |
11/12/2002 | CA2049668C Bioerodible implants |
11/12/2002 | CA2038637C Pharmaceutical iodine compositions |
11/12/2002 | CA2009533C Novel cyclosporin galenic forms |
11/11/2002 | CA2385510A1 Use of hydroxyflavanones for masking bitter taste |
11/07/2002 | WO2002088664A2 Control of compactability through crystallization |
11/07/2002 | WO2002088374A1 Process for producing isomaltose and use thereof |
11/07/2002 | WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production |
11/07/2002 | WO2002088246A1 Molded object having high pullulan content, process for producing the same, and use thereof |
11/07/2002 | WO2002087624A2 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |